The collaborators will improve access to Tiotropium Bromide Inhalation Powder in the U.S. for patients with COPD.
Mark Cuban Cost Plus Drug Company partners with pharma company, COPD Foundation
The collaborators will improve access to Tiotropium Bromide Inhalation Powder in the U.S. for patients with COPD.
